-
161
Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort
Published 2015-01-01“…The anti-dsDNA antibodies are a marker for Systemic Lupus Erythematosus (SLE) and 70–98% of patients test positive. …”
Get full text
Article -
162
Mucor and Aspergillus Maxillary Bone and Sinuses coinfection in a woman with Systemic Lupus Erythematosus: A Case Report
Published 2025-01-01Subjects: Get full text
Article -
163
Minimal Change Disease as a Secondary and Reversible Event of a Renal Transplant Case with Systemic Lupus Erythematosus
Published 2015-01-01“…In this paper we report a case of a 27-year-old Latina woman, a renal transplant recipient with systemic lupus erythematosus (SLE), who developed nephrotic range proteinuria 6 months after transplantation. …”
Get full text
Article -
164
The Role of Circulating Regulatory T Cell Levels on Subclinical Atherosclerosis and Cardiovascular Risk Factors in Women with Systemic Lupus Erythematosus
Published 2018-01-01“…The increase in cardiovascular disease (CVD) in patients with systemic lupus erythematosus (SLE) is not fully explained by traditional CVD risk factors. …”
Get full text
Article -
165
M1 and M2 Macrophage Polarization Correlates with Activity and Chronicity Indices in Lupus Nephritis
Published 2025-01-01Subjects: “…systemic lupus erythematosus…”
Get full text
Article -
166
Effect of trace elements and nutrients on 21 autoimmune diseases: a Mendelian randomization study
Published 2025-01-01Subjects: Get full text
Article -
167
The Role of Prolactin as a Disease Activity Indicator in Some Rheumatic Diseases
Published 2025-07-01Subjects: “…rheumatoid arthritis systemic lupus erythematosus…”
Get full text
Article -
168
Overlap of IgG4-Related disease with autoimmune rheumatic diseases: Report of 2 cases and review of literature
Published 2022-01-01Subjects: Get full text
Article -
169
Systemic Lupus Erythematosus, Its Impact on Selected Cardiovascular Risk Factors, and Correlation with Duration of Illness: A Pilot Study
Published 2020-01-01“…Systemic lupus erythematosus is a rare autoimmune disease. It leads to an increased production of proinflammatory molecules that accelerates atherogenesis and could cause an endothelium dysfunction. …”
Get full text
Article -
170
Platelet-to-lymphocyte ratio as a biomarker of systemic inflammation in systemic lupus erythematosus: A meta-analysis and systematic review.
Published 2024-01-01“…<h4>Objective</h4>The objective of this study was to evaluate the relationship between the platelet-to-lymphocyte ratio (PLR) and systemic lupus erythematosus (SLE). Additionally, the study aimed to establish an association between PLR and SLE disease activity, specifically lupus nephritis (LN).…”
Get full text
Article -
171
-
172
-
173
-
174
Polymorphism rs3828903 within MICB Is Associated with Susceptibility to Systemic Lupus Erythematosus in a Northern Han Chinese Population
Published 2016-01-01“…The variant rs3828903 within MICB, a nonclassical MHC class I chain-related gene, was detected to contribute to systemic lupus erythematosus (SLE) in a Caucasian population. …”
Get full text
Article -
175
-
176
-
177
A Possible Role of HMGB1 in DNA Demethylation in CD4+ T Cells from Patients with Systemic Lupus Erythematosus
Published 2013-01-01“…The aberrant activity of CD4+ T cells in patients with systemic lupus erythematosus (SLE) is associated with DNA hypomethylation of the regulatory regions in CD11a and CD70 genes. …”
Get full text
Article -
178
-
179
Enhancement of CD8+T cell cytotoxicity activity by IFN-α implies alternative pathologic role in systemic lupus erythematosus
Published 2025-06-01Subjects: “…Systemic lupus erythematosus (SLE)…”
Get full text
Article -
180
Exploring cardiovascular implications in systemic lupus erythematosus: A holistic analysis of complications, diagnostic criteria, and therapeutic modalities, encompassing pharmacological and adjuvant approaches
Published 2024-11-01Subjects: “…systemic lupus erythematosus…”
Get full text
Article